Drug Shortage Report for EPIRUBICIN HYDROCHLORIDE INJECTION
Report ID | 1081 |
Drug Identification Number | 02264927 |
Brand name | EPIRUBICIN HYDROCHLORIDE INJECTION |
Common or Proper name | EPIRUBICIN |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | EPIRUBICIN HYDROCHLORIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10mg/5mL x 1 |
ATC code | L01DB |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2014-10-14 |
Actual start date | 2014-11-29 |
Estimated end date | Unknown |
Actual end date | 2017-09-04 |
Shortage status | Resolved |
Updated date | 2018-07-26 |
Company comments | It has been discontinued (report ID 15441) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-07-26 | French | Compare |
v3 | 2018-07-26 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 4 of 4